NCT00501423

Antiplatelet Drug Resistances and Ischemic Events

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 771 (actual)
• Sponsor: Pierre Fontana · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The ADRIE study is an observational study on the clinical relevance of platelet reactivity in aspirin and clopidogrel treated cardiovascular patients.

Detailed description

The ADRIE study is an observational study on the clinical relevance of platelet reactivity in aspirin and clopidogrel treated cardiovascular patients. Main objective: * to determine if platelet reactivity, assessed by specific and non-specific tests, is predictive of ischemic events during the 3-year follow-up. Secondary objectives: * primary outcome in each pre-specified sub-group : patients with coronary artery disease, ischemic stroke or peripheral arterial disease as main qualifying disease at entry, * to determine if platelet reactivity, assessed by specific and non-specific tests, is predictive of bleeding events during the 3-year follow-up, * to investigate potential determinants of platelet reactivity at entry in the study

Conditions

• Symptomatic Atherothrombosis

Timeline

• Start date: 2006-06-01
• Primary completion: 2010-09-01
• Completion: 2010-09-01
• First posted: 2007-07-16
• Last updated: 2014-01-31

Locations

1 site across 1 country: France